Artigo do mês de maio 2020

Ray KK, et al. Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes. JAMA. 2020;323(16):1565–1573.